# A Drug-drug Interaction Study Between Daclatasvir and Atazanavir/Ritonavir or Atazanavir/Cobicistat

> **NCT02565888** · PHASE1 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 16 (actual)

## Conditions studied

- Hepatitis C
- HIV

## Interventions

- **DRUG:** Daclatasvir
- **DRUG:** Atazanavir
- **DRUG:** Ritonavir
- **DRUG:** Cobicistat

## Key facts

- **NCT ID:** NCT02565888
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02565888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02565888, "A Drug-drug Interaction Study Between Daclatasvir and Atazanavir/Ritonavir or Atazanavir/Cobicistat". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02565888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*